Study Comparing Etanercept With Usual DMARD Therapy in Subjects With Rheumatoid Arthritis in the Asia Pacific Region
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy of etanercept with usual
disease-modifying anti-rheumatic drug (DMARD) therapy in the treatment of moderate to severe
rheumatoid arthritis (RA) over 16 weeks in the Asia Pacific region.